Skip to main content
Caplight Logo









Suzhou Otovia Therapeutics Co., Ltd.

Suzhou Otovia Therapeutics Co., Ltd.

Private
ShanghaiHealthcare & Life Scienceshttps://otoviatx.com/

Last Round

VC Round

Jan 4, 2026

Company Overview

Suzhou Otovia Therapeutics Co., Ltd. is a biotechnology company that develops AAV-based gene therapies for the treatment of hearing loss and related neurodegenerative conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapyadeno-associated virusAAVcongenital deafnessgenetic hearing lossOTOF geneinner ear therapygene replacementclinical stage biotechdual AAV platformneurodegenerative diseaseprecision medicinegenetic medicinehearing restorationbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Suzhou Otovia Therapeutics Co., Ltd. Comparables

Compare Suzhou Otovia Therapeutics Co., Ltd. with similar companies based on industry and business-model similarity.

Suzhou Otovia Therapeutics Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Skylark Bio
86%
Shanghai Refreshgene Technology Co., Ltd.
81%
Eli Lilly and Company
79%

Suzhou Otovia Therapeutics Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 4, 2026
AngelJan 1, 2022

Suzhou Otovia Therapeutics Co., Ltd. Investors

Notable investors and investment history

Suzhou Otovia Therapeutics Co., Ltd. investors
InvestorRounds
Dingxin CapitalVC Round
南京市创新投资集团有限责任公司VC Round

Suzhou Otovia Therapeutics Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Suzhou Otovia Therapeutics Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Suzhou Otovia Therapeutics Co., Ltd.'s valuation, stock price, and market status.

Is Suzhou Otovia Therapeutics Co., Ltd. a public or private company?

Suzhou Otovia Therapeutics Co., Ltd. is a private company.

What is the current stock price of Suzhou Otovia Therapeutics Co., Ltd.?

Suzhou Otovia Therapeutics Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is Suzhou Otovia Therapeutics Co., Ltd. worth (valuation)?

Valuation information for Suzhou Otovia Therapeutics Co., Ltd. is not publicly available.

Can I buy Suzhou Otovia Therapeutics Co., Ltd. stock?

Suzhou Otovia Therapeutics Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Suzhou Otovia Therapeutics Co., Ltd.'s last funding round?

Suzhou Otovia Therapeutics Co., Ltd.'s most recent funding round was VC Round on January 4, 2026.

Who are the main investors in Suzhou Otovia Therapeutics Co., Ltd.?

Key investors in Suzhou Otovia Therapeutics Co., Ltd. include Dingxin Capital, 南京市创新投资集团有限责任公司.

Will Suzhou Otovia Therapeutics Co., Ltd. IPO soon?

No public IPO plans have been announced for Suzhou Otovia Therapeutics Co., Ltd..

How can I track Suzhou Otovia Therapeutics Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Suzhou Otovia Therapeutics Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersShanghai
Year Founded2022
Last FundingJan 4, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?